Form 4: Boston Scientific Executive Reports Stock Transactions

Boston Scientific EVP and CFO Jonathan Monson reported transactions involving restricted stock units and common stock.

Summary

• Jonathan Monson, EVP and CFO of Boston Scientific Corp, reported a transaction on July 1, 2026.
• He acquired 2,087 restricted stock units (RSUs) with a reported value of $0.0000.
• These RSUs are set to vest and issue shares of common stock in four equal annual installments starting July 1, 2026.
• Monson also disposed of 1,010 shares of common stock for $43.06 per share on the same date.
• Following these transactions, Monson beneficially owns 40,073 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine insider stock transactions related to compensation rather than significant investment or divestment decisions.

Positives

• Acquisition of 2,087 restricted stock units, indicating continued equity incentive for the CFO.
• The RSUs are scheduled for issuance over four years, suggesting a long-term commitment and retention incentive.

Negatives

• Disposal of 1,010 shares of common stock, which could be interpreted as a reduction in direct ownership, though the context of RSUs may mitigate this concern.

Future Outlook

The filing indicates that shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2026, as part of the restricted stock unit grant.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions in publicly traded companies, providing transparency into executive stock ownership and trading activities within the medical device sector.

Stakeholder Impact

• Shareholders gain insight into executive compensation and potential stock sales, contributing to transparency.
• Employees may view the RSU grants as a positive indicator of management's long-term commitment and incentive structure.

Next Steps

• Issuance of common stock in four equal annual installments for the acquired RSUs, starting July 1, 2026.

Key Dates

Keywords

Boston Scientific, BSX, Form 4, Insider Trading, Stock Transaction, Restricted Stock Units, EVP and CFO, Jonathan Monson